1. Home
  2. IIIV vs EMBC Comparison

IIIV vs EMBC Comparison

Compare IIIV & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo i3 Verticals Inc.

IIIV

i3 Verticals Inc.

HOLD

Current Price

$22.55

Market Cap

494.9M

Sector

Technology

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.99

Market Cap

524.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IIIV
EMBC
Founded
2012
1924
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
494.9M
524.1M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
IIIV
EMBC
Price
$22.55
$3.99
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$33.20
$18.50
AVG Volume (30 Days)
293.3K
626.3K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
6.88%
EPS Growth
N/A
20.90
EPS
0.02
0.74
Revenue
N/A
N/A
Revenue This Year
$9.05
$1.17
Revenue Next Year
$8.07
N/A
P/E Ratio
$1,165.50
$12.55
Revenue Growth
N/A
N/A
52 Week Low
$19.89
$8.47
52 Week High
$33.97
$15.55

Technical Indicators

Market Signals
Indicator
IIIV
EMBC
Relative Strength Index (RSI) 53.75 14.86
Support Level $22.12 N/A
Resistance Level $23.52 $9.54
Average True Range (ATR) 0.94 0.38
MACD 0.19 -0.32
Stochastic Oscillator 55.49 0.93

Price Performance

Historical Comparison
IIIV
EMBC

About IIIV i3 Verticals Inc.

i3 Verticals Inc provides mission-critical enterprise software solutions to public sector entities. These comprehensive cloud-native solutions address a broad range of government functions, including courts and public safety, public administration, utilities, transportation and schools. The company generates the majority of revenue from software and related services, including the sale of subscriptions, recurring services, ongoing support, licenses, and installation and implementation services specific to software.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: